AI-enhanced drug design software enters early access program

DeepMirror, a University of Cambridge spin-out, introduces its Early Access Programme for intuitive design software dedicated to discovering innovative therapeutic drugs. Click to read more...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Boston , Massachusetts , United States , Andrew Mcteague , Max Jakobs , Boston Consulting Group , University Of Cambridge , Early Access Programme , Wellcome , Lead Optimisation , Wellcome Trust , Boston Consulting , Senior Scientist , Medicinal Chemistry , Morphic Therapeutic , Drug , Discovery , Eepmirror , Design , User , Software , Herapeutic , Friendly , Head , Programme ,